Graham Capital Management, L.P. Immunocore Holdings PLC Transaction History
Graham Capital Management, L.P.
- $4.85 Billion
- Q3 2025
A detailed history of Graham Capital Management, L.P. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Graham Capital Management, L.P. holds 13,125 shares of IMCR stock, worth $471,843. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,125
Previous 14,696
10.69%
Holding current value
$471,843
Previous $461,000
3.25%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding IMCR
# of Institutions
145Shares Held
46.9MCall Options Held
325KPut Options Held
1.74M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.06MShares$254 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$175 Million2.36% of portfolio
-
Wellington Management Group LLP Boston, MA4.78MShares$172 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.75MShares$135 Million0.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.8MShares$101 Million2.17% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...